Association Between Migraine and Non-Alcoholic Fatty Liver Disease (NAFLD): A Hospital-Based Observational Study

Authors

  • Adarsh Kumar Sonkar Resident Doctor, MBBS, MD, Internal Medicine, Jawaharlal Nehru Medical College (JNMC), Aligarh Muslim University (AMU), Aligarh, Uttar Pradesh, India Author
  • Anjum Mirza Chughtai Professor, MBBS, MD, Internal Medicine, Internal Medicine, Jawaharlal Nehru Medical College (JNMC), Aligarh Muslim University (AMU), Aligarh, Uttar Pradesh, India Author

DOI:

https://doi.org/10.61336/jdme.0704.22

Keywords:

Migraine, Non-Alcoholic Fatty Liver Disease, NAFLD, Aura, Oxidative Stress, Liver Enzymes, Metabolic Syndrome

Abstract

Background: Migraine is a complex neurovascular disorder characterized by recurrent disabling headaches, while non-alcoholic fatty liver disease (NAFLD) represents a hepatic manifestation of metabolic dysfunction. Emerging evidence suggests shared metabolic, inflammatory, and oxidative pathways linking these two conditions, yet their interrelationship remains poorly elucidated in the Indian population. Objectives: To evaluate the association between migraine and NAFLD, to analyze the pattern and severity of headache in NAFLD patients with migraine, and to assess correlations between migraine characteristics and biochemical markers of NAFLD. Methods: A hospital-based, open-label observational study was conducted in the Departments of General Medicine and Radiodiagnosis, Jawaharlal Nehru Medical College, Aligarh. Ninety-four clinically diagnosed migraine patients were enrolled after informed consent and ethical clearance. Each participant underwent anthropometric evaluation, liver function testing, lipid profiling, and ultrasonographic screening for NAFLD. Statistical analysis was performed using SPSS version 16.0, applying Chi-square and unpaired t-tests, with significance set at p<0.05. Results: Among 94 patients, 84% were female and 30.9% experienced migraine with aura. The majority were aged below 30 years. Alanine aminotransferase (ALT) levels were significantly higher in patients with aura (38.62±19.41 U/L) compared to those without (31.25±14.06 U/L; p = 0.04). Alkaline phosphatase also showed a significant difference (p = 0.01). No significant variations were observed in anthropometric, blood pressure, or lipid parameters. However, patients with aura had markedly higher attack frequency (9.17±3.04 vs 5.58±2.45 months; p = 0.001), greater attack severity (6.12±0.99 vs 3.87±1.39; p = 0.001), and longer attack duration (30.66±22.23 h vs 12.03±12.24 h; p = 0.001). The presence of hepatic grade (GRD) correlated significantly with aura occurrence (p = 0.0001). Conclusion: The study demonstrates a significant association between migraine—particularly migraine with aura—and biochemical markers of NAFLD, indicating a possible role of hepatic metabolic dysregulation and oxidative stress in migraine pathophysiology. Early identification of NAFLD in migraine patients could help mitigate long-term vascular and metabolic complications.

Downloads

Published

2026-11-10

Similar Articles

41-50 of 63

You may also start an advanced similarity search for this article.